Chas. Pfizer & Co., Inc., v. Zenith Laboratories, Inc., and Continental Vitamins Corp. Continental Vitamins Corp., Appellant, 339 F.2d 602 (3d Cir. 1964)
Annotate this CaseDecided December 31, 1964
Appeal from the United States District Court for the District of New Jersey; Thomas F. Meany, Judge.
Abraham J. Nydick, New York City (Wilentz, Goldman & Spitzer, Perth Amboy, on the brief), for appellant.
Arthur G. Connolly, Connolly, Bove & Lodge, Wilmington, Del. (James R. E. Ozias, McCarter & English, Newark, N. J., Thomas S. Lodge, F. L. Peter Stone, Wilmington, Del., on the brief), for appellee.
Before BIGGS, Chief Judge, and FORMAN and SMITH, Circuit Judges.
PER CURIAM.
We have examined and re-examined the record in this case and have weighed the arguments of the parties. It is clear that the court below did not err in its decree of December 16, 1964 (entered December 17, 1964), denying a motion by the defendant-appellant, Continental Vitamins Corp., to enjoin the plaintiff-appellee, Chas. Pfizer & Co., Inc., inter alia, from proceeding with the prosecution of a civil suit instituted by the plaintiff against Barry-Martin Pharmaceuticals, Inc., in the United States District Court for the Southern District of Florida, Miami Division, viz., Civil Action No. 64-175-Civ.-EC.
Consequently, the decree appealed from will be affirmed.
Some case metadata and case summaries were written with the help of AI, which can produce inaccuracies. You should read the full case before relying on it for legal research purposes.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
